High Use of Short-Acting Β2-Agonists in COPD is Associated with an Increased Risk of Exacerbations and Mortality.Christer Janson,Fredrik Wiklund,Gunilla Telg,Georgios Stratelis,Hanna SandelowskyERJ Open Research（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
